Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vaxart Inc
(NQ:
VXRT
)
0.8623
+0.0393 (+4.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vaxart Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Recap: Vaxart Q4 Earnings
February 24, 2022
Vaxart (NASDAQ:VXRT) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Vaxart...
Via
Benzinga
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
February 17, 2022
Macy's Inc (NYSE:M) retail stores have something for everyo...
Via
Benzinga
Vaxart: Oral Covid-19 Vaccine Is Interesting, But Questions Linger
January 10, 2022
VXRT stock is more than a Covid-19 meme trade. But is there enough fundamentals there to support an investment heading into 2022?
Via
InvestorPlace
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street
December 29, 2021
Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current
Via
Talk Markets
Vaxart Deserves More Respect on Wall Street for Its Promising Covid-19 Vaccine
December 21, 2021
As the Covid-19 vaccine maker expands into a second manufacturing facility, VXRT stock remains an undervalued gem.
Via
InvestorPlace
Vaxart Stock Crosses 2 Key Levels Friday: What's Next?
December 17, 2021
Vaxart Inc. (NASDAQ:VXRT) shares were trading higher ...
Via
Benzinga
Vaxart Stock Breaks Out Of Pennant Pattern: Now What?
November 29, 2021
Vaxart Inc. (NASDAQ:VXRT) shares were trading higher ...
Via
Benzinga
Why Vaxart Stock Is About Ready To See A Breakout
November 24, 2021
Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Wednes...
Via
Benzinga
Vaxart to Test Cross-Reactivity of its COVID-19 Oral Vaccine Against Omicron
December 16, 2021
Vaxart Inc (NASDAQ: VXRT) plans to test the cross-reactivity of its oral tablet COVID-19 vaccine candidate against the omicron SARS-CoV-2 variant in two different...
Via
Benzinga
VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down
December 01, 2021
Despite a new factory acquisition, VXRT stock is down 9% on the day as 'Mad Money' host Jim Cramer warns investors about Vaxart.
Via
InvestorPlace
Cramer Gives His Opinion On Nokia, Delta Air Lines And More
December 01, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said DigitalOcean Holdings, Inc. (NYSE:
Via
Benzinga
Vaxart Stock Is Being Squeezed At The End Of A Pattern
November 18, 2021
Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Thursd...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
November 02, 2021
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
Don’t Write Off Vaxart, As Its Oral Vaccine Still Has a Chance
October 20, 2021
Vaxart stock is still worth a shot, as there's still big potential demand for a "no-needle" Covid-19 vaccine alternative.
Via
InvestorPlace
Exposures
COVID-19
Can This COVID Vaccine Stock Help Make You Rich?
October 16, 2021
This biotech has a nifty trick potentially up its sleeve.
Via
The Motley Fool
Exposures
COVID-19
Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up
October 12, 2021
Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesd...
Via
Benzinga
NASDAQ:VLDR Shareholder Notice: Update in Lawsuit Against Velodyne Lidar, Inc.
October 12, 2021
San Diego, CA -- (SBWIRE) -- 10/12/2021 -- An update was announced in the lawsuit that was filed for certain investors in shares of Velodyne Lidar, Inc. (NASDAQ:VLDR).
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
NASDAQ:VXRT Investor Alert: Update in Lawsuit Against Vaxart, Inc.
October 12, 2021
San Diego, CA -- (SBWIRE) -- 10/12/2021 -- An update was announced in the lawsuit that was filed for certain investors in shares of Vaxart, Inc. (NASDAQ:VXRT).
Via
SBWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?
October 10, 2021
The company is working on a vaccine candidate that doesn't involve a needle.
Via
The Motley Fool
Why Vaxart Shares Are Trading Higher Today
October 08, 2021
Vaxart Inc (NASDAQ: VXRT) is trading higher Friday after the company reported a Duke University-led study published in bioRxiv showed that the company's investigational...
Via
Benzinga
18 Stocks Moving in Friday's Pre-Market Session
October 08, 2021
Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine...
Via
Benzinga
Why Vaxart Shares Are Surging In Thursday's After-Hours Session
October 07, 2021
Vaxart Inc (NASDAQ: VXRT) is surging higher in after-hours trading Thursday after the company reported a Duke University-led study published in bioRxiv showed that the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 07, 2021
Gainers Vaxart (NASDAQ:VXRT) shares incr...
Via
Benzinga
Why Vaxart Stock Tumbled in September
October 07, 2021
A COVID-19 antiviral pill may undermine the biotech's value proposition.
Via
The Motley Fool
Exposures
COVID-19
Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial
October 06, 2021
Vaxart Inc (NASDAQ: VXRT) has begun recruiting subjects for its Phase 2 COVID-19 oral tablet vaccine clinical trial. Related: FDA Clears Vaxart's...
Via
Benzinga
Exposures
COVID-19
Product Safety
Why Investing in VXRT Stock is a Coin Flip
October 06, 2021
Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine.
Via
InvestorPlace
Exposures
COVID-19
What's Going On With Vaxart's Stock?
October 05, 2021
Vaxart Inc. (NASDAQ: VXRT) shares traded higher Tuesday after a study titled "A Phase 2 Trial With an Oral Tableted Covid-19 Vaccine" was posted to Clinicaltrials.gov....
Via
Benzinga
Exposures
COVID-19
Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today
October 01, 2021
Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector.
Via
InvestorPlace
Exposures
COVID-19
Vaxart Traders Should Not Dismiss the Vaccine Maker’s Momentum
September 27, 2021
The recently range-bound price action of VXRT stock doesn't reflect the progress that Vaxart is making against Covid-19.
Via
InvestorPlace
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
September 23, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.